John W. Rose,
MD
Chief, Division of Neuroimmunology
No Rating Available?
31 4.8
out of
5
Patient Rating
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the
minimum.
Languages Spoken: English
John Rose, MD, is professor of neurology at the University of Utah and is chief of neurology at the Salt Lake City Veterans Administration Hospital. Dr. Rose and his colleagues investigate diverse aspects of multiple sclerosis (MS), including the immunopathology of MS and related models, the development of new treatments for MS, early disease detection with advanced magnetic resonance imaging, and the detection of susceptibility genes for MS.
Clinical Locations
801-585-7575
Specialties
Board Certification and Academic Information
| Academic Departments | Neurology
-
Professor |
| Academic Divisions | Neuroimmunology |
| Board Certification | American Board of Psychiatry & Neurology (Neurology) National Board of Medical Examiners |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.9/ 5
Care provider's explanation of condition/problem
4.8/ 5
Care provider's effort to include me in decisions
4.8/ 5
Wait time at clinic
4.6/ 5
Care provider's concern for questions & worries
4.8/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
December 24, 2021
CLINICAL NEUROSCIENCES CENTER
Dr. Rose is wonderful and has been for 25+ years
UofU Patient
November 27, 2021
CLINICAL NEUROSCIENCES CENTER
Dr. Rose is one of the best physicians in the world! His advice and care is practical and invaluable.
UofU Patient
November 23, 2021
CLINICAL NEUROSCIENCES CENTER
We love Dr. Rose
UofU Patient
November 19, 2021
CLINICAL NEUROSCIENCES CENTER
Dr. Rose is very professional and one to whom I have recommended to others.
UofU Patient
October 19, 2021
CLINICAL NEUROSCIENCES CENTER
Dr. Rose knew exactly what was going on when he talked to me, examined me and discussed symptoms
UofU Patient
September 07, 2021
CLINICAL NEUROSCIENCES CENTER
Dr. Rose is the best!! He is so kind and knowledgeable.
UofU Patient
September 01, 2021
CLINICAL NEUROSCIENCES CENTER
Dr Rose is very attuned to his patient and their needs and concerns. He responds on the patients level of understanding so both parties comprehend.
UofU Patient
August 07, 2021
CLINICAL NEUROSCIENCES CENTER
Dr Rose Rocks! He's the best! A living legend.
UofU Patient
July 31, 2021
IMAGING AND NEUROSCIENCES CENTER
I feel that sometimes it's not helpful to have the medical students in EVERY appt because it sometimes feels like they get so caught up in talking medical stuff to each other they forget to talk to me. The patient. The one who lives in the body and knows it better than anyone.
UofU Patient
July 26, 2021
IMAGING AND NEUROSCIENCES CENTER
Didn't inform me of any risks from taking the new medication only benefits.
UofU Patient
July 16, 2021
IMAGING AND NEUROSCIENCES CENTER
Dr Rose gave great information.
UofU Patient
June 24, 2021
IMAGING AND NEUROSCIENCES CENTER
Dr. Rose is very good about treating you like any actual person.
UofU Patient
June 20, 2021
IMAGING AND NEUROSCIENCES CENTER
Dr. Rose takes time to listen. he does not seem rushed.
UofU Patient
June 16, 2021
IMAGING AND NEUROSCIENCES CENTER
I've recommended dr rose to a few of my MSer friends. I am so happy with the care he has given me these past 17? Years
UofU Patient
June 05, 2021
IMAGING AND NEUROSCIENCES CENTER
very happy
UofU Patient
May 29, 2021
IMAGING AND NEUROSCIENCES CENTER
I love Dr Rose!! He has been my provider for 12+ years. I trust him completely!!
UofU Patient
May 20, 2021
IMAGING AND NEUROSCIENCES CENTER
I feel SOOOO lucky to have Dr. Rose, Julia Klein ( who I didn't see this time. ) Having one of the best in the country makes having this insidious disease a little more bearable.
UofU Patient
May 06, 2021
IMAGING AND NEUROSCIENCES CENTER
hood
UofU Patient
May 02, 2021
IMAGING AND NEUROSCIENCES CENTER
Was a good visit with Dr. Rose and his associates!
UofU Patient
April 29, 2021
IMAGING AND NEUROSCIENCES CENTER
i love dr rose and dr poon and their colleague (i forgot her name unfortunately)
UofU Patient
April 08, 2021
IMAGING AND NEUROSCIENCES CENTER
Dr. Rose is the best!
UofU Patient
March 23, 2021
IMAGING AND NEUROSCIENCES CENTER
Dr. Rose is consistently attentive, and his the attending doctor was very personable and engaged. This is typical of my experience.
UofU Patient
March 20, 2021
IMAGING AND NEUROSCIENCES CENTER
always love talking to Dr. Rosehe's the very best
UofU Patient
March 11, 2021
IMAGING AND NEUROSCIENCES CENTER
Dr Rose is the best!
UofU Patient
February 16, 2021
IMAGING AND NEUROSCIENCES CENTER
Explained everything as the visited proceeded.
UofU Patient
January 28, 2021
IMAGING AND NEUROSCIENCES CENTER
all great
UofU Patient
May 05, 2020
IMAGING AND NEUROSCIENCES CENTER
I was satisfied in every way with my appointment
UofU Patient
May 03, 2020
IMAGING AND NEUROSCIENCES CENTER
I enjoy Dr Rose. He is very smart and actually takes his time to assess and explain. He is very patient and listens to your concerns.
UofU Patient
April 13, 2020
IMAGING AND NEUROSCIENCES CENTER
My appointment was not at the clinic. it was done in Virtual Zoom. It wasn't as personable, but it was ok.
UofU Patient
February 23, 2020
IMAGING AND NEUROSCIENCES CENTER
Both Dr. Rose and his Fellow (cant remember her name) were professional, caring and took time to explain things to me
UofU Patient
February 16, 2020
IMAGING AND NEUROSCIENCES CENTER
Dr. Rose is always very thorough and so kind and helpful. His fellow was also great.
John Rose, MD, is professor of neurology at the University of Utah and is chief of neurology at the Salt Lake City Veterans Administration Hospital. Dr. Rose and his colleagues investigate diverse aspects of multiple sclerosis (MS), including the immunopathology of MS and related models, the development of new treatments for MS, early disease detection with advanced magnetic resonance imaging, and the detection of susceptibility genes for MS.
Academic Locations
Board Certification and Academic Information
| Academic Departments | Neurology
-
Professor |
| Academic Divisions | Neuroimmunology |
| Board Certification | American Board of Psychiatry & Neurology (Neurology) National Board of Medical Examiners |
Education History
| Fellowship | National Institute of Health Neuroimmunology (July 1981 to June 1985) Fellow, 1985 |
| Fellowship | National Institute of Health Neurology (July 1979 to June 1980) Fellow, 1980 |
| Chief Resident | University of Maryland Neurology (July 1978 to June 1978) Chief Resident, 1979 |
| Residency | University of Maryland Neurology (July 1976 to June 1979) Resident, 1978 |
| Internship | Maryland General Hospital Medicine (July 1975 to June 1976) Intern, 1976 |
| Professional Medical | University of Maryland Medicine (September 1971 to June 1975) M.D., 1975 |
| Undergraduate | Johns Hopkins University Biology (September 1969 to June 1971) B.A., 1971 |
Selected Publications - Journal Articles
Journal Article
- Abbatemarco JR, Galli JR, Sweeney ML, Carlson NG, Samara VC, Davis H, Rodenbeck S, Wong KH, Paz Soldan MM, Greenlee JE, Rose JW, Delic A, Clardy SL (2021). Modern Look at Transverse Myelitis and Inflammatory Myelopathy: Epidemiology of the National Veterans Health Administration Population. Neurol Neuroimmunol Neuroinflamm, 8(6).
- Greenberg BM, Casper TC, Mar SS, Ness JM, Plumb P, Liang S, Goyal M, Weinstock-Guttman B, Rodriguez M, Aaen GS, Belman A, Barcellos LF, Rose JW, Gorman MP, Benson LA, Candee M, Chitnis T, Harris YC, Kahn IL, Roalstad S, Hart J, Lotze TE, Rensel M, Rubin JP, Schreiner TL, Tillema JM, Waldman AT, Krupp L, Graves J, Drake K, Waubant E (2021). Familial History of Autoimmune Disorders Among Patients With Pediatric Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm, 8(5).
- Villani LA, Stulberg EL, Abbatemarco JR, Davidson CJ, Kadish R, Renner DR, Soldan MMP, Rose JW, Clardy SL, Greenlee JE (2021). Biopsy-proven PML in an HIV-negative patient with discoid lupus: Failure to detect JC virus in CSF. Clin Neurol Neurosurg, 209, 106843.
- Burt RK, Balabanov R, Han X, Quigley K, Arnautovic I, Helenowski I, Rose J, Siddique T (2020). Autologous Hematopoietic Stem Cell Transplantation for Stiff-Person Spectrum Disorder: A Clinical Trial. Neurology, 96(6), e817-e830.
- Jeong K, Shah LM, Lee YJ, Thapa B, Sapkota N, Bisson E, Carlson NG, Jeong EK, Rose JW (2021). High-b diffusivity of MS lesions in cervical spinal cord using ultrahigh-b DWI (UHb-DWI). Neuroimage Clin, 30, 102610.
- Wallach AI, Waltz M, Casper TC, Aaen G, Belman A, Benson L, Chitnis T, Gorman M, Graves J, Harris Y, Lotze TE, Mar S, Moodley M, Ness JM, Rensel M, Rodriguez M, Rose JW, Schreiner T, Tillema JM, Waubant E, Weinstock-Guttman B, Charvet LE, Krupp LB (2019). Cognitive processing speed in pediatric-onset multiple sclerosis: Baseline characteristics of impairment and prediction of decline. Mult Scler, 26(14), 1938-1947.
- Chan A, Rose J, Alvarez E, Bar-Or A, Butzkueven H, Fox RJ, Gold R, Gudesblatt M, Haartsen J, Spelman T, Wright K, Ferraro D, Sola P, Hodgkinson S, Kalincik T, Lechner-Scott J, McGuigan C, Spach K, Chen C, Fam S, Wu F, Miller C (2021). Lymphocyte reconstitution after DMF discontinuation in clinical trial and real-world patients with MS. Neurol Clin Pract, 10(6), 510-519.
- Santoro JD, Waltz M, Aaen G, Belman A, Benson L, Gorman M, Goyal MS, Graves JS, Harris Y, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Rensel M, Rodriguez M, Schreiner T, Tillema JM, Waubant E, Weinstock-Guttman B, Hurtubise BF, Roalstad S, Rose J, Casper TC, Chitnis T, US Network of Pediatric MS Centers (2020). Pediatric Multiple Sclerosis Severity Score in a large US cohort. Neurology, 95(13), e1844-e1853.
- Chitnis T, Aaen G, Belman A, Benson L, Gorman M, Goyal MS, Graves JS, Harris Y, Krupp L, Lotze T, Mar S, Ness J, Rensel M, Schreiner T, Tillema JM, Waubant E, Weinstock-Guttman B, Roalstad S, Rose J, Weiner HL, Casper TC, Rodriguez M, US Network of Paediatric Multiple Sclerosis Centers (2019). Improved relapse recovery in paediatric compared to adult multiple sclerosis. Brain, 143(9), 2733-2741.
- Graves JS, Barcellos LF, Krupp L, Belman A, Shao X, Quach H, Hart J, Chitnis T, Weinstock-Guttman B, Aaen G, Benson L, Gorman M, Greenberg B, Lotze T, Soe M, Ness J, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waldman A, Casper TC, Waubant E (2019). Vitamin D genes influence MS relapses in children. Mult Scler, 26(8), 894-901.
- Krysko KM, Graves JS, Rensel M, Weinstock-Guttman B, Rutatangwa A, Aaen G, Belman A, Benson L, Chitnis T, Gorman M, Goyal MS, Harris Y, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waltz M, Casper TC, Waubant E, US Network of Pediatric MS Centers (2020). Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis. Ann Neurol, 88(1), 42-55.
- Lord J, Paz Soldan MM, Galli J, Salzman KL, Kresser J, Bacharach R, DeWitt LD, Klein J, Rose J, Greenlee J, Clardy SL (2020). Neurosarcoidosis: Longitudinal experience in a single-center, academic healthcare system. Neurol Neuroimmunol Neuroinflamm, 7(4).
- Cook LJ, Rose JW, Alvey JS, Jolley AM, Kuhn R, Marron B, Pederson M, Enriquez R, Yearley J, McKechnie S, Han MH, Tomczak AJ, Levy M, Mealy MA, Coleman J, Bennett JL, Johnson R, Barnes-Garcia M, Traboulsee AL, Carruthers RL, Lee LE, Schubert JJ, McMullen K, Kister I, Rimler Z, Reid A, Sicotte NL, Planchon SM, Cohen JA, Ivancic D, Sedlak JL, Sand IK, Repovic P, Amezcua L, Pruitt A, Amundson E, Chitnis T, Mullin DS, Klawiter EC, Russo AW, Riley CS, Onomichi KB, Levine L, Nelson KE, Nealon NM, Engel C, Kruse-Hoyer M, Marcille M, Tornes L, Rumpf A, Greer A, Kenneally Behne M, Rodriguez RR, Behne DW, Blackway DW, Coords B, Blaschke TF, Sheard J, Smith TJ, Behne JM, Yeaman MR, Guthy-Jackson Charitable Foundation International Clinical Consortium GJCFICC (2019). Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD. Neurol Neuroimmunol Neuroinflamm, 6(5), e583.
- Rhead B, Shao X, Graves JS, Chitnis T, Waldman AT, Lotze T, Schreiner T, Belman A, Krupp L, Greenberg BM, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee MS, Gorman M, Benson L, Mar S, Kahn I, Rose J, Casper TC, Quach H, Quach D, Schaefer C, Waubant E, Barcellos LF, US Network of Pediatric MS Centers (2019). miRNA contributions to pediatric-onset multiple sclerosis inferred from GWAS. Ann Clin Transl Neurol, 6(6), 1053-1061.
- Aaen G, Waltz M, Vargas W, Makhani N, Ness J, Harris Y, Casper TC, Benson L, Candee M, Chitnis T, Gorman M, Graves J, Greenberg B, Lotze T, Mar S, Tillema JM, Rensel M, Rodriguez M, Rose J, Rubin J, Schreiner T, Waldman A, Weinstock-Guttman B, Belman A, Waubant E, Krupp L (2018). Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis. J Child Neurol, 34(3), 148-152.
- Chi C, Shao X, Rhead B, Gonzales E, Smith JB, Xiang AH, Graves J, Waldman A, Lotze T, Schreiner T, Weinstock-Guttman B, Aaen G, Tillema JM, Ness J, Candee M, Krupp L, Gorman M, Benson L, Chitnis T, Mar S, Belman A, Casper TC, Rose J, Moodley M, Rensel M, Rodriguez M, Greenberg B, Kahn L, Rubin J, Schaefer C, Waubant E, Langer-Gould A, Barcellos LF (2019). Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry. PLoS Genet, 15(1), e1007808.
- Burt RK, Balabanov R, Burman J, Sharrack B, Snowden JA, Oliveira MC, Fagius J, Rose J, Nelson F, Barreira AA, Carlson K, Han X, Moraes D, Morgan A, Quigley K, Yaung K, Buckley R, Alldredge C, Clendenan A, Calvario MA, Henry J, Jovanovic B, Helenowski IB (2019). Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial. JAMA, 321(2), 165-174.
- Thapa B, Sapkota N, Lee Y, Jeong K, Rose J, Shah LM, Bisson E, Jeong EK (2018). Ultra-high-b radial diffusion-weighted imaging (UHb-rDWI) of human cervical spinal cord. J Magn Reson Imaging, 49(1), 204-211.
- Gianfrancesco MA, Stridh P, Shao X, Rhead B, Graves JS, Chitnis T, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Mar S, Kahn I, Rose J, Roalstad S, Casper TC, Shen L, Quach H, Quach D, Hillert J, Hedstrom A, Olsson T, Kockum I, Alfredsson L, Schaefer C, Barcellos LF, Waubant E, Network of Pediatric Multiple Sclerosis Centers (2017). Genetic risk factors for pediatric-onset multiple sclerosis. Mult Scler, 24(14), 1825-1834.
- Cohan S, Kappos L, Giovannoni G, Wiendl H, Selmaj K, Havrdov EK, Rose J, Greenberg S, Phillips G, Ma W, Wang P, Lima G, Sabatella G (2017). Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE. Mult Scler, 24(14), 1883-1891.
- Krysko KM, Graves J, Rensel M, Weinstock-Guttman B, Aaen G, Benson L, Chitnis T, Gorman M, Goyal M, Krupp L, Lotze T, Mar S, Rodriguez M, Rose J, Waltz M, Charles Casper T, Waubant E, US Network of Pediatric MS Centers (2018). Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US. Neurology, 91(19), e1778-e1787.
- Mar S, Liang S, Waltz M, Casper TC, Goyal M, Greenberg B, Weinstock-Guttman B, Rodriguez M, Aaen G, Belman A, Barcellos LF, Rose J, Gorman M, Benson L, Candee M, Chitnis T, Harris Y, Kahn I, Roalsted S, Hart J, Lotze T, Moodley M, Ness J, Rensel M, Rubin J, Schreiner T, Tillema JM, Waldman A, Krupp L, Graves JS, Waubant E, US Network of Pediatric Multiple Sclerosis Centers (2018). Several household chemical exposures are associated with pediatric-onset multiple sclerosis. Ann Clin Transl Neurol, 5(12), 1513-1521.
- Lavery AM, Waubant E, Casper TC, Roalstad S, Candee M, Rose J, Belman A, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Ness J, Harris Y, Graves J, Krupp L, Charvet L, Benson L, Gorman M, Moodley M, Rensel M, Goyal M, Mar S, Chitnis T, Schreiner T, Lotze T, Greenberg B, Kahn I, Rubin J, Waldman AT (2018). Urban air quality and associations with pediatric multiple sclerosis. Ann Clin Transl Neurol, 5(10), 1146-1153.
- Nourbakhsh B, Rutatangwa A, Waltz M, Rensel M, Moodley M, Graves J, Casper TC, Waldman A, Belman A, Greenberg B, Goyal M, Harris Y, Kahn I, Lotze T, Mar S, Schreiner T, Aaen G, Hart J, Ness J, Rubin J, Tillema JM, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Candee M, Weinstock-Guttman B, Shao X, Barcellos L, James J, Waubant E, US Network of Pediatric MS Centers (2018). Heterogeneity in association of remote herpesvirus infections and pediatric MS. Ann Clin Transl Neurol, 5(10), 1222-1228.
- Pakpoor J, Seminatore B, Graves JS, Schreiner T, Waldman AT, Lotze TE, Belman A, Greenberg BM, Weinstock-Guttman B, Aaen G, Tillema JM, McDonald JC, Hart J, Ness JM, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Mar S, Kahn I, Rose J, Carmichael SL, Roalstad S, Waltz M, Casper TC, Waubant E, US Network of Pediatric Multiple Sclerosis Centers (2017). Dietary factors and pediatric multiple sclerosis: A case-control study. Mult Scler, 24(8), 1067-1076.
- Suleiman L, Waubant E, Aaen G, Belman A, Benson L, Candee M, Chitnis T, Gorman M, Goyal M, Greenberg B, Harris Y, Hart J, Kahn I, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Nourbakhsh B, Rensel M, Rodriguez M, Rose J, Rubin J, Schreiner T, Tillema JM, Waldman A, Weinstock-Guttman B, Casper TC, Waltz M, Graves JS, Network of Pediatric Multiple Sclerosis Centers (2018). Early infectious exposures are not associated with increased risk of pediatric-onset multiple sclerosis. Mult Scler Relat Disord, 22, 103-107.
- Katz Sand I, Fabian MT, Telford R, Kraus TA, Chehade M, Masilamani M, Moran T, Farrell C, Ebel S, Cook LJ, Rose J, Lublin FD (2018). Open-label, add-on trial of cetirizine for neuromyelitis optica. Neurol Neuroimmunol Neuroinflamm, 5(2), e441.
- Azary S, Schreiner T, Graves J, Waldman A, Belman A, Guttman BW, Aaen G, Tillema JM, Mar S, Hart J, Ness J, Harris Y, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Barcellos LF, Lotze T, Carmichael SL, Roalstad S, Casper CT, Waubant E (2017). Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis. J Neurol Neurosurg Psychiatry, 89(1), 28-33.
- Lavery AM, Waldman AT, Charles Casper T, Roalstad S, Candee M, Rose J, Belman A, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Ness J, Harris Y, Graves J, Krupp L, Benson L, Gorman M, Moodley M, Rensel M, Goyal M, Mar S, Chitnis T, Schreiner T, Lotze T, Greenberg B, Kahn I, Rubin J, Waubant E, US Network of Pediatric MS Centers (2017). Examining the contributions of environmental quality to pediatric multiple sclerosis. Mult Scler Relat Disord, 18, 164-169.
- Baldassari LE, Rose JW (2017). Daclizumab: Development, Clinical Trials, and Practical Aspects of Use in Multiple Sclerosis. Neurotherapeutics, 14(4), 842-858.
- Rose JW, Giovannoni G, Wiendl H, Gold R, Havrdov E, Kappos L, Selmaj KW, Zhao J, Riester K, Tsao LC, Greenberg SJ (2017). Consistent efficacy of daclizumab beta across patient demographic and disease activity subgroups in patients with relapsing-remitting multiple sclerosis. Mult Scler Relat Disord, 17, 32-40.
- Sapkota N, Shi X, Shah LM, Bisson EF, Rose JW, Jeong EK (2016). Two-dimensional single-shot diffusion-weighted stimulated EPI with reduced FOV for ultrahigh-b radial diffusion-weighted imaging of spinal cord. Magn Reson Med, 77(6), 2167-2173.
- Gianfrancesco MA, Stridh P, Rhead B, Shao X, Xu E, Graves JS, Chitnis T, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Mar S, Kahn I, Rose J, Roalstad S, Casper TC, Shen L, Quach H, Quach D, Hillert J, Brnhielm M, Hedstrom A, Olsson T, Kockum I, Alfredsson L, Metayer C, Schaefer C, Barcellos LF, Waubant E, Network of Pediatric Multiple Sclerosis Centers (2017). Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS. Neurology, 88(17), 1623-1629.
- Bourne T, Waltz M, Casper TC, Kavak K, Aaen G, Belman A, Benson L, Candee M, Chitnis T, Graves J, Greenberg B, Gorman M, Harris Y, Krupp L, Lotze T, Mar S, Ness J, Olsen C, Roalstad S, Rodriguez M, Rose J, Rubin J, Schreiner T, Tillema JM, Kahn I, Waldman A, Barcellos L, Waubant E, Weinstock-Guttman B, US Network of Pediatric MS Centers (2017). Evaluating the association of allergies with multiple sclerosis susceptibility risk and disease activity in a pediatric population. J Neurol Sci, 375, 371-375.
- Nourbakhsh B, Graves J, Casper TC, Lulu S, Waldman A, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Ness J, Rubin J, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Barcellos L, Waubant E, Network of Pediatric Multiple Sclerosis Centers (2016). Dietary salt intake and time to relapse in paediatric multiple sclerosis. J Neurol Neurosurg Psychiatry, 87(12), 1350-1353.
- Chitnis T, Graves J, Weinstock-Guttman B, Belman A, Olsen C, Misra M, Aaen G, Benson L, Candee M, Gorman M, Greenberg B, Krupp L, Lotze T, Mar S, Ness J, Rose J, Rubin J, Schreiner T, Tillema J, Waldman A, Rodriguez M, Casper C, Waubant E, US Network of Pediatric MS Centers (2016). Distinct effects of obesity and puberty on risk and age at onset of pediatric MS. Ann Clin Transl Neurol, 3(12), 897-907.
- Sapkota N, Yoon S, Thapa B, Lee Y, Bisson EF, Bowman BM, Miller SC, Shah LM, Rose JW, Jeong EK (2016). Characterization of spinal cord white matter by suppressing signal from hindered space. A Monte Carlo simulation and an ex vivo ultrahigh-b diffusion-weighted imaging study. J Magn Reson, 272, 53-59.
- Belman AL, Krupp LB, Olsen CS, Rose JW, Aaen G, Benson L, Chitnis T, Gorman M, Graves J, Harris Y, Lotze T, Ness J, Rodriguez M, Tillema JM, Waubant E, Weinstock-Guttman B, Casper TC, US Network of Pediatric MS Centers (2016). Characteristics of Children and Adolescents With Multiple Sclerosis. Pediatrics, 138(1).
- Tremlett H, Fadrosh DW, Faruqi AA, Hart J, Roalstad S, Graves J, Lynch S, Waubant E, US Network of Pediatric MS Centers (2016). Gut microbiota composition and relapse risk in pediatric MS: A pilot study. Apr 16(363), 153-157.
- McDonald J, Graves J, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema J, Rodriquez M, Chitnis T, Mar S, Barcellos L, Laraia B, Rose JW, Roalstad S, Simmons T, Casper TC, Waubant E (2016). A case-control study of dietary salt intake in pediatric-onset multiple sclerosis. Mult Scler Relat Disord, 6(Mar 2016), 87-92.
- Chitnis T, Ness J, Krupp L, Waubant E, Hunt T, Olsen CS, Rodriguez M, Lotze T, Gorman M, Benson L, Belman A, Weinstock-Guttman B, Aaen G, Graves J, Patterson M, Rose JW, Casper TC (2015). Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report. Neurology, 86(3), 245-52.
- Graves J, Barcellos LF, Shao X, Noble J, Mowry EM, Quach H, Belman A, Casper TC, Krupp LB, Waubant E (2016). The US Network of Pediatric Multiple Sclerosis Centers: Genetic predictors of relapse rate in pediatric MS. Mult Scler, 1-8.
- Loughran-Fjeldstad AS, Carlson NG, Husebye CD, Cook LJ, Rose JW (2015). Retinal nerve fiber layer sector-specific compromise in relapsing and remitting multiple sclerosis. eNeurologicalSci, 1, 30-37.
- Kappos L, Wiendle H, Selmaj K, Arnold DL, Havrdova E, Boyko A, Kaufman M, Rose JW, Greenberg S, Sweetser M, Riester K, ONeill G, Elkins J (2015). Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis. N Engl J Med, 373(15), 1418-28.
- Casper TC, Rose JW, Roalstad S, Waubant E, Aaen G, Belman A, Chitnis T, Gorman M, Krupp L, Lotze TE, Ness J, Patterson M, Rodriguez M, Weinstock-Guttman B, Browning B, Graves J, Tillema JM, Benson L, Harris Y, US Network of Pediatric Multiple Sclerosis Centers (2014). The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps. J Child Neurol, 30(10), 1381-7.
- Carlson NG, Bellamkonda S, Schmidt L, Redd J, Huecksteadt T, Weber LM, Davis E, Wood B, Maruyama T, Rose JW (2015). The role of the prostaglandin E2 receptors in vulnerability of oligodendrocyte precursor cells to death. J Neuroinflammation, 12, 101.
- Graves J, Grandhe S, Weinfurtner K, Krupp L, Belman A, Chitnis T, Ness J, Weinstock-Guttman B, Gorman M, Patterson M, Rodriguez M, Lotze T, Aaen G, Mowry EM, Rose JW, Simmons T, Casper TC, James J, Waubant E, US Network of Pediatric Multiple Sclerosis Centers (2014). Protective environmental factors for neuromyelitis optica. Neurology, 83(21), 1923-9.
- Charvet LE, ODonnell EH, Belman AL, Chitnis T, Ness JM, et al (2014). Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the "US Pediatric Multiple Sclerosis Network". Mult Scler, 20(11), 1502-10.
- Charvet LE, Cleary RE, Vazquez K, Belman AL, Krupp LB (2014). Social cognition in pediatric-onset multiple sclerosis (MS). Mult Scler, 20(11), 1478-84.
- Casper TC, Rose JW, Roalstad S, Waubant E, Aaen G, Belman A, Chitnis T, Gorman M, Krupp L, Lotze TE, Ness J, Patterson M, Rodriguez M, Weinstock-Guttman B, Browning B, Graves J, Tillema JM, Benson L, Harris Y (2014). The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps. J Child Neurol, 09/30/2014, 1-7.
- Sheridan JP, Robinson RR, Rose JW (2014). Daclizumab, an IL-2 modulating antibody for treatment of multiple sclerosis. Expert Rev Clin Pharmacol, 7(1), 9-19.
- Sato F, Martinez NE, Shahid M, Rose JW, Carlson NG, Tsunoda I (2013). Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis. Am J Pathol, 183(5), 1390-1396.
- Seo HS, Kim SE, Rose JW, Hadley JR, Parker DL, Jeong EK (2013). Diffusion tensor imaging of extraocular muscle using two-dimensional single-shot interleaved multiple inner volume imaging diffusion-weighted EPI at 3 tesla. J Magn Reson Imaging, 38(5), 1162-1168.
- Yonnet GJ, Fjeldstad AS, Carlson NG, Rose JW (2014). Advances in the management of neurogenic detrusor overactivity in multiple sclerosis. Int J MS Care, 15(2), 66-72.
- Carlson NG, Rose JW (2013). Vitamin D as a clinical biomarker in multiple sclerosis. Expert Opin Med Diagn, 7(3), 231-42.
- Martins TB, Rose JW, Gardiner GL, Kusukawa N, Husebye D, Hill HR (2013). Cell-based reporter gene assay for therapy-induced neutralizing antibodies to interferon-beta in multiple sclerosis. J Interferon Res, 33(2), 52-7.
- Fjeldstad AS, Carlson NG, Rose JW (2012). Optical coherence tomography as a biomarker in multiple sclerosis. Expert Opin Med Diagn, 6(6), 593-604.
- Rose JW (2012). Anti-CD25 immunotherapy: regulating the regulators. Sci Transl Med, 4(145), 145fs25.
- Merrill RP, Hadley JR, Minalga E, Kholmovski EG, Vijayakumar S, Kim SE, Quigley EP, Parker DL, Rose JW (2012). A 28-channel coil array for improved imaging of the optic nerve. Sci Transl Med, 41B(3), 73-84.
- Langer HF, Choi EY, Zhou H, Schleicher R, Chung KJ, Tang Z, Gobel K, Bdeir K, Chatzigeorgiou A, Wong C, Bhatia S Kruhlak MJ, Rose JW, Burns JB, Hill KE, Qu H, Zhang Y, Lehrmann E, Becker KG, Wang Y, Simon DI, Nieswandt B, Lambris JD, Li X, Meuth SG, Kubes P, Chavakis T (2012). Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circ Res, 110(9), 1202-10.
- Fjeldstad AS, McDaniel J, Witman MA, Ives SJ, Zhao J, Rose JW, Hannon J, Wray DW, Richardson RS (2011). Vascular function and multiple sclerosis. J Neurol, 258(11), 2036-42.
- Martins TB, Rose JW, Jaskowski TD, Wilson AR, Husebye D, Seraj HS, Hill HR (2011). Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoassay. Am J Clin Pathol, 136(5), 696-704.
- Waldman AT, Gorman MP, Rensel MR, Austin Te, Hertz DP, et al (2011). Management of pediatric central nervous system demyelinating disorders: consensus of United States neurologists. J Child Neurol, 26(6), 675-82.
- Rose JW, Carlson NG (2011). Clinical biomarkers in multiple sclerosis. Expert Opin Med Diagn, 5(3), 213-26.
- Zollinger LV, Kim TH, Hill K, Jeong EK, Rose JW (2011). Using diffusion tensor imaging and immunofluorescent assay to evaluate the pathology of multiple sclerosis. J Magn Reson Imaging, 33(3), 557-64.
- Minalga E, Rose JW, Choi SE, Jeong EK, Kholmovski E, et al (2011). A 20-channel coil for improved magnetic resonance imaging of the optic nerve. Concepts Magn Reson Part B Magn Reson Eng, 25(39B(1)), 26-36.
- Carlson NG, Rojas MA, Redd JW, Tang P, Wood B, Hill KE, Rose JW (2010). Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death. J Neuroinflammation, 7, 25.
- Wynn D, Kaufman M, Montalban X, Vollmer T, Simon J, Elkins J, ONeill G, Neyer L, Sheridan J, Wang C, Fong A, Rose JW, CHOICE investigators (2010). Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta. Lancet Neurol, 9(4), 381-90.
- Kim TH, Zollinger L, Shi XF, Kim SE, Rose J, Patel AA, Jeong EK (2010). Quantification of diffusivities of the human cervical spinal cord using a 2D single-shot interleaved multisection inner volume diffusion-weighted echo-planar imaging technique. AJNR Am J Neuroradiol, 31(4), 682-7.
- Ford C, Goodman AD, Johnson K, Kachuck N, Lindsey JW, Lisak R, Luzzio C, Myers L, Panitch H, Preiningerova J, Pruitt A, Rose J, Rus H, Wolinski J (2010). Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate. Mult Scler, Mar(3), 342-50.
- Brettschneider J, Jaskowski TD, Tumani H, Abdul S, Husebye D, Seraj H, Hill HR, Fire E, Spector L, Yarden J, Dotan N, Rose JW (2009). Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases. J Neuroimmunol, 217(1-2), 95-101.
- Hill KE, Clawson SA, Rose JW, Carlson NG, Greenlee JE (2009). Cerebellar Purkinje cells incorporate immunoglobulins and immunotoxins in vitro: implications for human neurological disease and immunotherapeutics. J Neuroinflammation, 6, 31.
- Rojas MA, Carlson NG, Miller TL, Rose JW (2009). Long-term daclizumab therapy in relapsing-remitting multiple sclerosis. Ther Adv Neurol Disord, 2(5), 291-7.
- Rose JW (2009). Multiple sclerosis: evidence of maternal effects and an increasing incidence in women. Neurology, 73(8), 587-9.
- Rose JW, Foley JF, Carlson NG (2009). Monoclonal antibody treatments for multiple sclerosis. Curr Treat Options Neurol, 11(3), 211-20.
- Mehta LR, Rose JW (2009). Recurrent granuloma annulare during treatment with daclizumab. Mult Scler, 15(4), 527-8.
- Carlson NG, Rojas MA, Black JD, Redd JW, Hille J, Hill KE, Rose JW (2009). Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor. J Neuroinflammation, 6, 5.
- Wolinski JS, Sochat T, Weiss S, Ladkani D PROMiSe Trial Study Group J Rose site PI (2009). Glatiramer acetate treatment in PPMS: why males appear to respond favorably. J Neurol Sci, 15, 286-928.
- Kim T, Zollinger L, Shu X, Rose JW, Jeong E (2009). Diffusion tensor imaging of ex vivo cervical spinal cord specimens: the immediate and long term effects of fixation on diffusivity. Anat Rec, 292, 234-41.
- Burt RK, Loh Y, Cohen B, Stefoski D, Balabanov R, Katsamakis G, Oyama Y, Russell EJ, Stern J, Muraro P, Rose JW, Testori A, Bucha J, Jovanovic B, Milanetti F, Storek J, Volterelli JC, Burns WH (2009). Autologous non-myeloablative heamtopoetic stem cell transplantation for relapsing and remitting multiple sclerosis. Lancet Neurol, 8, 244-53.
- Wolinsky JS (2003). The diagnosis of primary progressive multiple sclerosis. J Neurol Sci, 206(2), 145-52.
Book Chapter
- Jacobson S, Rose J, Flerlage M, Mingioli E, McFarlin D, McFarland F (1986). Measles virus-specific human cytotoxic T cells generated in bulk cultures: Analysis of measles virus antigenic specificity. In Mahy BWJ (Ed.), The Biology of Negative Strand Viruses. Elsevier Biomedical Press.
Book Review
- Rose JW (1984). Neuroimmunology. [Review of the book ].
Editorial
- Rose JW (August 2012). Anti-CD25 immunotherapy: regulating the regulators. Sci Transl Med, 4(145), 145fs25.
- Rose JW (2009). Multiple sclerosis: evidence of maternal effects and an increasing incidence in women. Neurology, 73(8), 578-9.
- Rose J (2009). Multiple Sclerosis: Evidence of Maternal Effects and an Increasing Incidence in Women. Neurology, 73(8), 578-9.
Abstract
- Carlson NG, Schmidt L, Redd J, Bellamkonda S, Wood B, Weber LM, Paz Soldan MM, RoseJW (2015). Vulnerability of oligodendrocyte precursor cells to death is modulated by key prostaglandins [Abstract]. Finale Programme: ECTRIMS 31st Congress. Barcelona, Spain.
- Chitnis T, Graves J, Weinstock-Guttman B, Belman A, Misra M, Olsen CS, Aaen G, Benson L, Candee M, Gorman M, Greenberg B, Lotze T, Ness J, Rodriquez M, Rose JW, Rubin J, Schreiner T, Mendelt-Tillema J, Casper TC, Waubant E (2015). Effect of obesity and puberty on risk and age at onset of pediatric MS [Abstract]. Finale Programme: ECTRIMS 31st Congress. Barcelona, Spain.
- Aaen GS, Waltz M, Casper T, Ness J, Gorman M, Makahani N, Vargas W, Waubant E, Chitnis T, Lotze T, Graves J, Benson L, Tillema MJ, Rodriguez M, Rose JW, Weinstock-Guttman B, Krupp L, Belman A (10/08/2015). Acquisition of early developmental milestones and need for special education services in paediatric-onset multiple sclerosis [Abstract]. Finale Programme: ECTRIMS 31st Congress. Barcelona, Spain.
- Nourbakhsh B, Graves J, Lulu S, Waldman A, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema J-M, Hart J, Lee M, Ness J, Rubin J, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Simmons T, Casper C, Rose JW, Barcellos L, Waubant E (2015). Association of dietary salt intake and relapse rate in pediatric multiple sclerosis [Abstract]. Finale Programme: ECTRIMS 31st Congress. Barcelona, Spain.
- Loughran-Fjeldstad AS, Carlson NG, Cook LJ, Rose JW (2015). Longitudinal reduction of total macular volume in relapsing and remitting multiple sclerosis: indicative of ongoing neurodegeneration [Abstract]. Finale Programme: ECTRIMS 31st Congress. Barcelona, Spain.
- Wiendl H, Havrdova E, RoseJW, Giovannoni G, Tsao LC, Zhao J, Pan Q, Elkins J, Greenberg SJ (2015). Daclizumab high-yield process (DAC HYP) vs. intramuscular interferon beta-1a in subgroups predictive of active disease: results from the DECIDE study [Abstract]. Finale Programme: ECTRIMS 31st Congress. Barcelona, Spain.
- Katz Sand I, Fabian M, Cook L, Telford R, Chehade M, Masilamani M, Kraus T, Farrell C, Phelps S, Riffle ME, Rose JW, Moran T, Lublin F (2015). An open-label add-on trial of cetirizine for neuromyelitis optica: baseline data and preliminary results [Abstract]. Finale Programme: ECTRIMS 31st Congress. Barcelona, Spain.
- Arnold DL, Kappos L, Wiendl H, Selmaj K, Havrdova E, Boyko A, Kaufman M, Rose JW, Greenberg S, Amaravadi L, Riestger K, Elkins J (2015). Benefits on brain MRI lesion activity with Daclizumab HYP compared with intramuscular interferon beta- 1a are maintained through 144 weeks’ treatment: results from the DECIDE study [Abstract]. Finale Programme: ECTRIMS 31st Congress. Barcelona, Spain.
- Paz Soldan M, Schmidt L, Wood B, Rose JW, Carlson N (2015). Prostaglandin F2a Receptor Mediates Oligodendrocyte Precursor Injury/Death: Potential Rose in Multiple Sclerosis. Washington D.C [Abstract]. Neurology, 84(14 Supplement), P5.210.
- Selmaj K, Kappos L, Arnold D, Havrdova E, Boyko A, Kaufman M, Wiendl H, Rose JW, Greenberg S, Riester K, Sweetser M, Elkins J (2015). Safety and Tolerability Results from the DECIDE Study: A Phase 3 Active-comparator Study of Daclizumab HYP in Relapsing-remitting Multiple Sclerosis. [Abstract]. Neurology, 84(14 Supplement), P7.230.
- Rose JW, Wiendl H, Arnold D, Kappos L, Havrdova E, Selmaj K, Boyko A, Kaufman M, Greenberg S, Sweetser M, Riester K, Elkins J (2015). Daclizumab HYP Reduced Brain MRI Lesion Activity Compared with Interferon Beta-1a: Results from the DECIDE Study [Abstract]. Neurology, 84(14 Supplement), P7.252.
- Seminatore B, Graves J, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Ness J, Rubin J, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Mar S, Barcellos L, Rose JW, Roalstad S, Simmons T, Casper C, Waubant E (2015). Fat, Fiber, and Pediatric MS [Abstract]. Neurology, 84(14 Supplement), S38.002.
- McDonald J, Graves J, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tilleman JM, Hart J, Ness J, Rubin J, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Mar S, Barcellos L, Rose JW, Roalstad S, Simmons T, Casper TC, Waubant E (2015). A Case-control Study of Dietary Salt Intake and Risk of Pediatric Multiple Sclerosis (MS). Washington D.C. [Abstract]. Neurology, 84(14 Supplement), S38.003.
- Kappos L, Selmaj K, Arnold D, Havrdova E, Boyko A, Kaufman M, Wiendl H, Rose JW, Greenberg S, Sweetser M, Riester K, Elkins J (2015). Daclizumab HYP Versus Interferon Beta-1a in Relapsing-remitting Multiple Sclerosis: Primary Results of the DECIDE Study [Abstract]. Neurology, 84(14 Suppliment), S4.003.
- Wang V, Clardy T, Rose JW, Burns J, Carlson N, Greenlee J, Clardy S (2015). Neuromyelitis Optica in Veterans [Abstract]. Neurology, 84(14 Supplement), P1.104.
- Sand IK, Fabian M, Cook L, Chehade M, Masilamani M, Kraus T, Farrell C, Phelps S, Riffle ME, Rose JW, Moran T, Lublin F (2015). An Open Label Add-on Trial of Cetirizine for Neuromyelitis Optica [Abstract]. Neurology, 84(14 Supplement), P4.003.
- Wiendl H, Havrdova E, Rose JW, Riester K, Tsao C, Greenberg S (2015). Daclizumab HYP Versus Interferon β-1a Across Patient Demographic and Disease Activity Subgroups in the DECIDE Phase 3 Study [Abstract]. Neurology, 84(14 Supplement), P4.007.
- Tremlett H, Fadrosh D, Lynch S, Hart J, Gravas J, Lulu S, Aaen G, Belman A, Benson L, Casper C, Chitnis T, Gorman M, Krupp L, Lotze T, Ness J, Roalstac S, Rodriquez M, Rose JW, Tillema JM, Weinstock-Guttman B, Waubant E (2015). Gut Microbiome in Early Pediatric Multiple Sclerosis: A Case-control Study [Abstract]. Neurology, 84(14 Supplement), P4.027.
- Carlson N, Rojas M, Redd J, Tang P, Wood B, Hill K, Rose JW (2009). Cyclooxygenase-2 expression in oligodendrocytes increases sensitiity to excitotoxic death [Abstract]. European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Dusseldorf, Germany.
- Rose JW, Quigley E, Anderson J, Kim S, Jeong EK, Minalga E, Merrill R, Parker D, Hadley R (2009). Imaging of the optic nerve with improved radiofrequency toils for 3T MRI. [Abstract]. First International Conference on Inflammation and Retinal Disease: Complement Biology and Pathology, Knossos, Crete.
- Tumani H, Brettschneider J, Jakowski T, Abdul S, Husebye D, Seraj H, Hill H, Fire E, Spector L, Dotan N, Rose JW (2009). Anti-GAGA4 IgM assay may distinguish primary progressive multiple sclerosis from relapsing remitting multiple sclerosis patients. [Abstract]. ACTRIMS, Atlanta, Geogia.
- Merrill R, Hadley R, Minalga E, Parker D, Vijayakumar S, Choi SEK, Bell L, Rose JW (2009). An improved 28 channel array for optic nerve imaging [Abstract]. International Society for Magnetic Resonance Imaging.
- Kim T, Kim SE, Patel A, Zollinger L, Rose JW, Jeong EK (2009). Diffusion tensor imaging of human spinal cords in cervical myelopathy [Abstract]. International Society for Magnetic Resonance Imaging, Honolulu, Hawaii.
- Rose JW, Jaskowski T, Husebye D, Seraj H, Hill H, Carlson N (2008). Anti-thyroid antibodies identify a subgroup of multiple sclerosis patients. [Abstract]. ECTRIMS, Montreal, Canada.
- Carlson N, Rojas M, Black J-D, Redd J, Hill K, Rose JW (2008). Neuroprotection by EP1 prostanoid receptor antagonists is modulated by microglia [Abstract]. Society for Neuroscience, Washington, DC.
- Tsunoda I, Rose JW, Carlson N (2008). Treatment on an animal model for MS with resveratrol, a red wine component [Abstract]. International Society for Neuroimmunology, Dallas, Texas.
- Carlson N, Rojas M, Redd J, Wood B, Hill K, Rose JW (2008). The role of COX-2 in experimental oligodendrocytes death and demyelination [Abstract]. International society for Neuroimmunology, Dallas, Texas.
- Carlson N, Rojas M, Redd J, Wood B, Hill K, Rose JW (2008). A COX-2 inhibitor limits demyelination in a murine model of MS and protects oligodendrocytes from excitotoxic death in culture. [Abstract]. ECTRIMS, Montreal, Canada.
- Mehta L, Rose JW (2008). Recurrent granuloma annulare occurring during treatment with daclizumab [Abstract]. ECTRIMS, Montreal, Canada.
- Jaskowski T, Husebye D, Yarden J, Spector L, Fire E, Dotan N, Hill H, Rose JW (2008). Performance of an anti-GAGA4 IgM assay in distinguishing MS patients from control groups in a US cohort: a cross sectional retrospective study [Abstract]. ECTRIMS, Montreal, Canada.
- Tsunoda I, Carlson N, Rose JW (2008). Treatment with a red wine component, resveratrol, in a virus induced model for MS [Abstract]. ECTRIMS, Montreal, Canada.
- Hadley R, Merrill R, Minalga E, Parker D, Rose JW (2008). Improved radio frequency coils for 3T magnetic resonance imaging of the optic nerve [Abstract]. ECTRIMS, Monteral, Canada.
- Burt R, Cohen B, Stefoski D, Balabanov R, Katsamakis G, Rose JW, Testori A, Muraro P, Storek J and Voltarelli J (2008). Autologous non myeloablative hematopoetic stem cell transplantation for relapsing multiple sclerosis [Abstract]. ECTRIMS, Montreal, Canada.